Anand Upadhyaya1, Laura R Marks1,2, Evan S Schwarz3,4, Stephen Y Liang1,2,3, Michael J Durkin1,2, David B Liss3,4. 1. Department of Internal Medicine, Washington University in St. Louis School of Medicine. 2. Division of Infectious Diseases, Washington University in St. Louis School of Medicine. 3. Department of Emergency Medicine, Washington University in St. Louis School of Medicine. 4. Division of Medical Toxicology, Washington University in St. Louis School of Medicine.
Abstract
OBJECTIVES: To define the care cascade for patients with serious injection drug use related infections (SIRI) in a tertiary hospital system and compare outcomes of those who did and did not participate in an opioid use disorder (OUD) treatment referral program. METHODS: The medical records of patients admitted with both OUD and SIRI including endocarditis, osteomyelitis, septic arthritis, epidural abscess, thrombophlebitis, myositis, bacteremia, and fungemia from 2016-2019 were retrospectively reviewed. Patient demographics, clinical covariates, 90-day readmission rates, and outcomes data were collected. We compared data from those who were successfully referred to outpatient care through Engaging Patients in Care Coordination (EPICC), a peer recovery specialist-run OUD treatment referral program, to those who did not receive outpatient referral. RESULTS: During the study period 334 persons who inject opioids were admitted with SIRI. Fourteen admitted patients died and were excluded from the analysis. The all-cause readmission rate was lower among patients referred to the EPICC program (18/76 [23.7%]) compared to those not referred to EPICC (100/244 [41.0%]) (OR 0.44; 95% CI 0.25 - 0.80). CONCLUSION: An OUD care cascade evaluation for patients with SIRI demonstrated that referral to peer recovery services with outpatient OUD treatment was associated with reduced 90-day readmission rate.
OBJECTIVES: To define the care cascade for patients with serious injection drug use related infections (SIRI) in a tertiary hospital system and compare outcomes of those who did and did not participate in an opioid use disorder (OUD) treatment referral program. METHODS: The medical records of patients admitted with both OUD and SIRI including endocarditis, osteomyelitis, septic arthritis, epidural abscess, thrombophlebitis, myositis, bacteremia, and fungemia from 2016-2019 were retrospectively reviewed. Patient demographics, clinical covariates, 90-day readmission rates, and outcomes data were collected. We compared data from those who were successfully referred to outpatient care through Engaging Patients in Care Coordination (EPICC), a peer recovery specialist-run OUD treatment referral program, to those who did not receive outpatient referral. RESULTS: During the study period 334 persons who inject opioids were admitted with SIRI. Fourteen admitted patients died and were excluded from the analysis. The all-cause readmission rate was lower among patients referred to the EPICC program (18/76 [23.7%]) compared to those not referred to EPICC (100/244 [41.0%]) (OR 0.44; 95% CI 0.25 - 0.80). CONCLUSION: An OUD care cascade evaluation for patients with SIRI demonstrated that referral to peer recovery services with outpatient OUD treatment was associated with reduced 90-day readmission rate.
Entities:
Keywords:
Endocarditis; Injection Drug Use; Opioid Use Disorder; Osteomyelitis; Retention in Care
Authors: Arthur Robin Williams; Edward V Nunes; Adam Bisaga; Frances R Levin; Mark Olfson Journal: Am J Drug Alcohol Abuse Date: 2019-01-24 Impact factor: 3.829
Authors: Sarah E Wakeman; Marc R Larochelle; Omid Ameli; Christine E Chaisson; Jeffrey Thomas McPheeters; William H Crown; Francisca Azocar; Darshak M Sanghavi Journal: JAMA Netw Open Date: 2020-02-05
Authors: Marc R Larochelle; Dana Bernson; Thomas Land; Thomas J Stopka; Na Wang; Ziming Xuan; Sarah M Bagley; Jane M Liebschutz; Alexander Y Walley Journal: Ann Intern Med Date: 2018-06-19 Impact factor: 25.391
Authors: Laura R Marks; Satish Munigala; David K Warren; Stephen Y Liang; Evan S Schwarz; Michael J Durkin Journal: Clin Infect Dis Date: 2019-05-17 Impact factor: 9.079
Authors: Honora Englander; Konrad Dobbertin; Bonnie K Lind; Christina Nicolaidis; Peter Graven; Claire Dorfman; P Todd Korthuis Journal: J Gen Intern Med Date: 2019-12 Impact factor: 5.128
Authors: Jesse L Yedinak; William C Goedel; Kimberly Paull; Rebecca Lebeau; Maxwell S Krieger; Cheyenne Thompson; Ashley L Buchanan; Tom Coderre; Rebecca Boss; Josiah D Rich; Brandon D L Marshall Journal: PLoS Med Date: 2019-11-19 Impact factor: 11.069
Authors: Arthur Robin Williams; Kimberly A Johnson; Cindy Parks Thomas; Sharon Reif; M Eugenia Socías; Brandy F Henry; Charles Neighbors; Adam J Gordon; Constance Horgan; Bohdan Nosyk; Karen Drexler; Noa Krawczyk; Gregg S Gonsalves; Scott E Hadland; Bradley D Stein; Marc Fishman; A Taylor Kelley; Harold A Pincus; Mark Olfson Journal: Subst Abus Date: 2022 Impact factor: 3.984
Authors: Sophia Lewis; Stephen Y Liang; Evan S Schwarz; David B Liss; Rachel P Winograd; Nathanial S Nolan; Michael J Durkin; Laura R Marks Journal: Open Forum Infect Dis Date: 2022-01-06 Impact factor: 3.835